Article info
PDFClinical and epidemiological research
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
- M Dastmalchi, Rheumatology, Unit, Karolinska University Hospital, Solna, SE-171 76 Stockholm, Sweden; maryam.dastmalchi{at}karolinska.se
Citation
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
Publication history
- Accepted January 28, 2008
- First published February 13, 2008.
Online issue publication
November 12, 2008
Article Versions
- Previous version (13 February 2008).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism